ENGLEWOOD, Colo., Sept. 3, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced order growth for July and August 2020. Aggregate […]
Tag: Zynex
Zynex Announces Second Quarter 2020 Earnings
– Revenue increased 87% year over year to $19.3 million – Orders increased 37% – Net income of $3.0 million; Diluted EPS $0.09 – Adjusted EBITDA increased 69% to $4.8 million ENGLEWOOD, Colo., July 28, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative […]
Zynex, Inc. Prices Public Offering of Common Stock
ENGLEWOOD, Colo., July 14, 2020 /PRNewswire/ — Zynex, Inc. (“Zynex”) (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today the pricing of its previously announced underwritten […]
Zynex Announces 37% Order Growth and Increases Q2 and Full-Year Revenue Estimates
ENGLEWOOD, Colo., July 9, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased revenue estimate for […]
Zynex Announces New Line of Products
ENGLEWOOD, Colo., May 18, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced it has introduced a full catalog […]
Zynex Announces 2020 First Quarter Earnings
– Revenue increased 66% year over year to $15.2 million – Orders increased 126% – Net income of $2.9 million; Diluted EPS $0.09 – Adjusted EBITDA increased 23% to $3.0 million ENGLEWOOD, Colo., April 28, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative […]
Zynex Announces 126% Order Growth and Increases Q1 and Full-Year Revenue Estimates
ENGLEWOOD, Colo., April 7, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased revenue estimate for Q1 […]
Zynex Announces 2019 Fourth Quarter and Full Year Earnings
ENGLEWOOD, Colo., Feb. 27, 2020 /PRNewswire/ — 2019 Full Year Revenue increased 42% year over year to $45.5 million Net income $9.5 million; Diluted EPS $0.28 2019 Revenue, net income and Adjusted EBITDA are the highest in Company history Adjusted EBITDA increased 11% to $12.1M 2019 […]
Zynex Receives FDA Clearance for its Blood Volume Monitor
ENGLEWOOD, Colo., Feb. 25, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced the U.S. Food and Drug Administration […]
Zynex Expands Corporate Headquarters to Accommodate Growth
ENGLEWOOD, Colo., Jan. 7, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it has signed an addendum to its […]